Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 18/12/20131 min de leitura
Pilot Program for Parallel Review of Medical Products; Extension of the Duration of the Program
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) (the Agencies) are announcing the extension of the "Pilot Program for Parallel Review of Medical Products." The Agencies have decided to continue the program as currently designed for an additional period of 2 years from the date of publication of this notice.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →